NDC 62795-1013

BHI Acne

Silver Nitrate, Arnica Montana, Atropa Belladonna, Bryonia Alba Root, Solanum Dulcamara Top, Echinacea Purpurea, Calcium Sulfide, Lachesis Muta Venom, Phytolacca Americana Root, Pulsatilla Vulgaris, Rancid Beef, Toxicodendron Pubescens Leaf, And Thuja Occidentalis Leafy Twig

BHI Acne is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Medinatura. The primary component is Silver Nitrate; Arnica Montana; Atropa Belladonna; Bryonia Alba Root; Solanum Dulcamara Top; Echinacea Purpurea; Calcium Sulfide; Lachesis Muta Venom; Phytolacca Americana Root; Pulsatilla Vulgaris; Rancid Beef; Toxicodendron Pubescens Leaf; Thuja Occidentalis Leafy Twig.

Product ID62795-1013_0fc9b5ab-6737-4997-b4a1-5d51755b5c22
NDC62795-1013
Product TypeHuman Otc Drug
Proprietary NameBHI Acne
Generic NameSilver Nitrate, Arnica Montana, Atropa Belladonna, Bryonia Alba Root, Solanum Dulcamara Top, Echinacea Purpurea, Calcium Sulfide, Lachesis Muta Venom, Phytolacca Americana Root, Pulsatilla Vulgaris, Rancid Beef, Toxicodendron Pubescens Leaf, And Thuja Occidentalis Leafy Twig
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-09-30
Marketing End Date2025-09-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameMediNatura
Substance NameSILVER NITRATE; ARNICA MONTANA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; SOLANUM DULCAMARA TOP; ECHINACEA PURPUREA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF; THUJA OCCIDENTALIS LEAFY TWIG
Active Ingredient Strength8 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC Exclude FlagN

Packaging

NDC 62795-1013-2

100 TABLET in 1 BOTTLE (62795-1013-2)
Marketing Start Date2014-09-30
Marketing End Date2025-09-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62795-1013-2 [62795101302]

BHI Acne TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-09-30

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.